Update on the treatment landscape for Renal Cell Carcinoma in Canada

CUA
3/8/22, 7:00 PM
America/New York GMT -4 summer

Description

OBJECTIVES:

  • Review new therapies available in RCC
  • Examine the impact on sequencing and patient management with new therapies in RCC
  • Review patient cases/determine which patient type would benefit from an IO/IO vs. IO/TKI therapy in RCC
Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Aly-Khan Lalani

Review new therapies available in RCC, Examine the impact on sequencing and patient management with new therapies in RCC, Review patient cases/determine which patient type would benefit from an IO/IO vs. IO/TKI therapy in RCC

Inglês

 

Speakers

Laurence Albiges

 

Link to the Event

Banner to the Event

Update on the treatment landscape for Renal Cell Carcinoma in Canada